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In introductory biology courses, the retina is often
described as a blank screen upon which an image of the
outside world is projected. But this simple metaphor
belies the extraordinary structural and functional complex-
ity of the retina. Far from being a flat, homogeneous
surface, the retina is a three-dimensional mosaic consisting
of six types of neuron, two types of glial cell, and a
network of endothelial cells that make up the retinal capil-
laries (see Figure 1). In a fully-developed retina, these
cells cooperate with one another to carry out the initial
steps of vision, converting light into electrochemical
signals that are transmitted along the optic nerve to the
brain, where they are processed and interpreted to form a
visual image. But how do retinal neurons, glia and
endothelial cells come together in the first place? And how
are their numbers and locations precisely matched to form
an intact, functional retina? Although the process is not
completely understood, several recent studies suggest that
communication between neurons, astrocytes and endothe-
lial cells early in development is critical for the generation
of retinal architecture.
One of the first clues to the nature of this communication
came from the observation, made more than 30 years ago,
that the development of blood vessels in the retina is
regulated by oxygen [1]. Exposure of animals to high
levels of oxygen during early development led to
obliteration of newly formed blood vessels in their retinas,
while reduction of oxygen below normal levels (hypoxia)
stimulated growth of new vessels. The mechanism under-
lying this effect remained a mystery until the early 1990s,
when two key discoveries were made [2]. The first was
the identification of vascular endothelial growth factor
(VEGF) as an important inducer of endothelial cell growth
and blood vessel development. The second was the obser-
vation that production of VEGF can be stimulated by
Figure 1
Architecture of the retina. When light enters
the eye, it must filter through a complex
network of blood vessels, glial cells
(astrocytes and Müller glia) and neurons
before reaching the photoreceptors at the
back of the retina. The photoreceptors (rods
and cones) convert the light into
electrochemical signals, and these are
integrated and transmitted by interneurons
(horizontal, bipolar, and amacrine cells) to the
retinal ganglion cells (RGCs) at the front of
the retina. The axons of retinal ganglion cells
converge to form the optic nerve, which exits
through the back of the eye and carries the
visual information to the brain. 
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hypoxia. These findings raised the possibility that VEGF
might mediate the effects of oxygen on retinal blood
vessel development.
A number of studies supported the notion that VEGF
levels in the retina can be elevated by subjecting animals
to hypoxia [3,4]. But in 1995, Jonathan Stone, Eli Keshet
and their co-workers [5] provided strong evidence that
VEGF plays a role in normal retinal development. They
performed a detailed analysis of VEGF production in the
retinas of developing rats and cats, and found that the
growth factor was produced in precisely the regions where
blood vessels were being generated. In these regions,
VEGF was made by glial cells — astrocytes and Müller
glia — just before blood vessel formation. Moreover, the
newly formed vessels expressed high-affinity VEGF
receptors, indicating that they are capable of responding to
the growth factor. Finally, secretion of VEGF by retinal
astrocytes increased in response to hypoxia and decreased
in response to high levels of oxygen, suggesting that astro-
cyte-derived VEGF could indeed mediate the effects of
oxygen on the retinal vasculature.
On the basis of these observations, Stone et al. [5]
proposed a model for how retinal blood vessels normally
develop (see Figure 2). According to this model, as retinal
neurons become metabolically active, they use up oxygen
in their environment, causing local hypoxia. This ‘physio-
logical’ hypoxia causes retinal astrocytes to secrete VEGF,
which promotes growth of endothelial cells and formation
of retinal blood vessels. Then, when the blood vessels
open up and carry oxygenated blood to the area, the
hypoxia is relieved, and VEGF production by astrocytes
decreases to baseline levels. In this manner, blood vessel
formation is matched to oxygen demand. 
This model not only helped explain the process of normal
blood vessel development in the retina, but also shed light
on the cause of a human disease called ‘retinopathy of pre-
maturity’. In this disease, premature infants who are
exposed to high levels of oxygen (to help them breathe
during a period when their lungs are not fully formed)
develop severe retinopathy that can lead to blindness.
The late stages of retinopathy of prematurity are charac-
terized by aberrant growth of blood vessels (neovascular-
ization) in the retina, and a number of studies suggested
that VEGF might be involved in this process [3,4]. But the
precise role of VEGF in the pathogenesis of retinopathy of
prematurity was unclear.
Once again, Stone and Keshet and their colleagues [6] col-
laborated to investigate this issue. Their studies suggested
that, when newborn animals (or premature infants) are
exposed to high levels of oxygen, their retinal astrocytes
stop producing VEGF, and this causes newly formed
blood vessels, which depend on the growth factor, to die.
Then, when animals are returned to normal air, which has
much less oxygen, the astrocytes turn back on and make
large amounts of VEGF. This sudden increase in VEGF
levels stimulates growth of new blood vessels, but these
vessels are weak and abnormally leaky — a side-effect of
excessive VEGF, which also acts to increase vascular per-
meability — and there are often so many of them that
they disrupt retinal architecture and cause loss of vision. 
Previous studies had indicated that blocking VEGF — or
providing supplemental oxygen to suppress its production
— during the second phase of retinopathy of prematurity
can help prevent neovascularization and improve vision
[7,8]. But on the basis of their findings, Alon et al. [6] sug-
gested that it might be more useful to intervene during
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Figure 2
Regulation of retinal architecture by cell–cell
communication. During normal development,
retinal ganglion cells (RGCs) secrete basic
fibroblast growth factor (bFGF) and platelet-
derived growth factor (PDGF), which stimulate
proliferation of astrocytes in the retina and
along the optic nerve. Metabolic activity of
retinal ganglion cells (and other neurons) may
deplete oxygen in the area, causing
‘physiological’ hypoxia. Retinal astrocytes
respond to this hypoxia by secreting vascular
endothelial growth factor (VEGF), which
stimulates growth of endothelial cells and
generation of retinal blood vessels. These
blood vessels carry oxygen to the area,
relieving the hypoxia and shutting off
production of VEGF by astrocytes. Exposure to
high oxygen levels, or dysregulation of PDGF
secretion, can lead to abnormal astrocyte and
blood vessel development, altered retinal
architecture and impairment of vision.
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the first phase of retinopathy of prematurity, when normal
blood vessels are being destroyed. They and others [9]
have demonstrated that, by supplying exogenous VEGF
to animals before they are exposed to high oxygen, newly-
formed vessels can be preserved and the severity of
retinopathy can be reduced.
The studies of Stone, Keshet and colleagues [5,6] make it
clear that astrocytes are critical in establishing the correct
number of blood vessels in the retina. But what determines
the number of astrocytes? Recent work by two groups sug-
gests that astrocyte growth is dependent on signals from
retinal neurons. The first group, led by William Richard-
son, had previously found that retinal ganglion cells, the
neurons that carry signals out of the retina, secrete platelet-
derived growth factor (PDGF), while retinal astrocytes
express the PDGF receptor [10]. This raised the possibility
that PDGF was somehow involved in communication
between retinal ganglion cells and astrocytes. 
To determine the nature of this communication, Richard-
son and colleagues [11] set out to alter PDGF levels in the
developing retina. First, they generated cells that secreted
a soluble form of the PDGF receptor, which would bind
any PDGF secreted by the retinal ganglion cells and
prevent it from reaching astrocytes. They implanted these
cells into the eyes of newborn rats, and examined the
effects on astrocyte development five days later. In control
animals that received no cells (or cells that did not make
soluble receptor), astrocytes and their processes had
spread across the whole inner surface of the retina to form
a rich, highly branched network. In contrast, in animals
implanted with soluble PDGF receptor-secreting cells,
the retinal astrocyte network was perturbed: astrocytes
migrated only half as far, and their processes were much
less branched than those of control animals. Similar results
were obtained when animals were injected with antibod-
ies against the PDGF receptor, which prevented astro-
cytes from responding to PDGF. These results indicated
that the development of the retinal astrocyte network was
dependent on PDGF from retinal ganglion cells.
To clarify how PDGF was acting, the investigators artifi-
cially increased the amount of PDGF available to develop-
ing astrocytes by generating transgenic mice that expressed
abnormally high levels of PDGF in their retinal ganglion
cells. When they examined the retinas of these animals,
they observed a dramatic overgrowth of astrocytes. This
suggested that PDGF worked by promoting astrocyte pro-
liferation. To examine this directly, the authors isolated
retinas from wild-type and transgenic animals, and counted
the number of astrocytes in each retina and the amount of
DNA in each cell. As expected, the transgenic animals had
two to four times as many astrocytes as controls. Moreover,
these astrocytes contained more DNA than control cells,
indicating that more of them had entered the cell cycle and
begun to divide. In other words, PDGF was inducing prolif-
eration of retinal astrocytes.
The consequences of this proliferation became apparent
when the researchers examined the vasculature of trans-
genic mice. As discussed above, astrocytes control the
development of retinal blood vessels by secreting VEGF.
In transgenic animals, the hyperproliferation of astrocytes
was accompanied by an overproduction of capillaries in
the retina. Early in life, many of these animals displayed
retinal bleeding. By adulthood, both astrocytes and blood
vessels had penetrated into the deeper layers of the retina
(in normal animals, they are found primarily on the inner
retinal surface), and the animals showed severely dis-
rupted retinal structure. The authors suggested that
PDGF, like VEGF, might play a role in some forms of
human retinopathy.
Interestingly, the ability of retinal ganglion cells to control
astrocyte proliferation is not restricted to the retina. The
axons of retinal ganglion cells extend out of the retina to
form the optic nerve, and the optic nerve, like the retina,
is lined with astrocytes. The second study, by Burne and
Raff [12], demonstrates that the proliferation of these
astrocytes is also regulated by retinal ganglion cells. The
first indication of this came from earlier studies of trans-
genic mice that expressed high levels of the survival-pro-
moting gene bcl-2 in their retinal ganglion cells [13].
These mice not only had increased numbers of retinal
ganglion cells, but increased numbers of optic nerve astro-
cytes as well. This suggested that the development or pro-
liferation of optic nerve astrocytes might depend on
signals from retinal ganglion cell axons.
To test this notion, the authors [12] studied the effects of
cutting the optic nerve, which causes degeneration of
retinal ganglion cell axons. When they examined astro-
cytes from cut optic nerves, they found a dramatic
decrease in proliferation compared to that seen in astro-
cytes from normal optic nerves, indicating that signals
from the axons are necessary for normal astrocyte prolifer-
ation. Interestingly, a similar drop in proliferation was
observed when the experiment was performed in mutant
mice whose optic nerves do not degenerate following tran-
section. This suggested that, even if retinal ganglion cell
axons were intact, they could not stimulate astrocyte pro-
liferation unless they were physically connected to the cell
bodies of retinal ganglion cells.
One possible reason that the axons had to be intact was so
that they could conduct electrical activity. In fact, previ-
ous studies [14] had shown that oligodendrocyte precur-
sors in the optic nerve depend on electrical activity in
retinal ganglion cell axons for their proliferation. However,
activity turned out not to be required for the mitogenic
effect of retinal ganglion cells on astrocytes, as injection of
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tetrodotoxin, which blocks electrical activity, did not have
the same effect as transection. In contrast, injection of
colchicine, which prevents transport down the axon, was
able to mimic the effects of transection. From these obser-
vations, the authors concluded that molecules transported
down retinal ganglion cell axons are required for the mito-
genic effect on astrocytes.
To explore the basis of this effect, the investigators cul-
tured optic nerve astrocytes in vitro in the presence or
absence of retinal ganglion cells. In the presence of retinal
ganglion cells, they found that the proliferation of astro-
cytes increased 20-fold. The investigators attempted to
mimic the mitogenic effect of retinal ganglion cells using a
variety of growth factors known to be secreted by these
cells, and found that only one, basic fibroblast growth
factor (bFGF), was effective. Notably, PDGF, which pro-
motes the proliferation of astrocytes within the retina, was
unable to stimulate astrocytes from the optic nerve. This
is particularly interesting, as retinal astrocytes are thought
to originate in the optic nerve [15,16]. These results indi-
cated that retinal ganglion cells control the development
of astrocytes in both the retina and the optic nerve, albeit
by different mechanisms.
The work of Stone, Keshet and colleagues [5,6], Fruttiger
et al. [11] and Burne and Raff [12] clearly demonstrates
that assembly of the retina and the optic nerve is regulated
by a series of intricate cell–cell interactions, and that inter-
ference with any of these interactions can lead to disrup-
tion of retinal architecture and impairment of vision. But
while these studies provide a clearer picture of how the
elements of the visual system are put together, a number
of important questions remain. For example, Stone et al.
[5] postulate that neuronal activity in the developing
retina results in local hypoxia, which induces astrocytes to
secrete VEGF; although this is a plausible hypothesis,
there is no direct evidence that such physiological hypoxia
occurs, or that it is in fact the stimulus for VEGF produc-
tion. Assuming that it is, the mechanism by which astro-
cytes sense changes in local oxygen levels, and the
signaling pathways that allow them to respond by secret-
ing VEGF, still remain to be elucidated. 
Similarly, the studies of Fruttiger et al. [11] and Burne and
Raff [12] leave little doubt that retinal ganglion cells can
control the proliferation of astrocytes by secreting soluble
factors, such as PDGF and bFGF. But what triggers the
secretion of these factors? And perhaps more importantly,
what shuts them off so that astrocyte proliferation and vas-
cularization do not continue unchecked? The approaches
these investigators have used to map out the circuitry thus
far — detailed analysis of cell–cell interactions and
specific manipulation of these interactions in vitro and in
vivo — will undoubtedly shed light on these issues in the
near future.
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